Embryonal tumours with multilayered rosettes (ETMR)

Embryonal tumours with multilayered rosettes (ETMR) are rare small round blue cell tumour of the central nervous system and are one of the most aggressive brain tumours usually encountered in children. 

Previously embryonal tumours with multilayered rosettes (ETMR) where known as embryonal tumour with abundant neuropil and true rosettes (ETANTR). This term has, however, been removed from the 2016 update to WHO classification of CNS tumours in favour of embryonal tumours with multilayered rosettes (ETMR) which incorporates not only ETANTR but also ependymoblastoma and CNS PNET which have also been removed from the classification) 6. This has resulted due to the presence of amplification of the C19MC region on chromosome 19 in both CNS PNET and ETANTR, suggesting that these are the one entity with variable growth pattern 6

ETMR occurs in children aged 4 and under, mostly in children under 2, and is more common in girls, unlike the other CNS embryonal tumours, in which boys are equally or more commonly affected. 

The clinical features are determined by the location and extent of the tumor, with most located supratentorially, being less commonly seen in the infratentorial region and very rarely in the spinal cord.  

Increased intracranial pressure, seizures, hemiparesis, cerebellar signs, cranial nerve palsies, and other neurologic deficits have all been reported. 

Embryonal tumors with multilayered rosettes (ETMS) are characterized by undifferentiated neuroepithelial cells resembling those of classic CNS PNET, abundant well-differentiated neuropil, and ependymoblastic rosettes scattered throughout paucicellular regions of neoplastic neuropil. Unlike medulloblastoma, ETMR has no epithelial-like formation. Instead, it has a very characteristic ependymoblastic rosettes in both highly cellular as well as acellular areas. 

Recently amplification of the C19MC region on chromosome 19 (19q13.42) has been identified as characteristic of these tumours, along with what historically had been termed CNS PNET. As a result both ETANTR and CNS PNET have been removed from the 2016 update of the WHO classification of CNS tumours and been replaced by the term embryonal tumor with multilayered rosettes (ETMR),
C19MC-altered (or ETMR-NOS if C19MC amplification is absent) 6

MRI

The tumour appears as a large, demarcated, solid mass featuring patchy or no contrast enhancement, with surrounding edema, often with significant mass effect. A minority of the reported cases have shown cystic components and microcalcifications. 

  • T1: decreased intensity
  • T2: increased intensity
  • T1 C+ (Gd): patchy or no contrast enhancement

MR spectroscopy shows choline peak and a high ratio of choline/aspartate suggesting hypercellularity of the tumour. 

Current treatment options for ETMR include surgical resection, systemic chemotherapy and craniospinal radiation (when appropriate). 

Unfortunately, the prognosis is dismal, with most recent articles reporting ~75% of cases have died within the median survival of 9 months. 

The differential diagnosis varies according to the location of the tumour. The general imaging differential for the brain stem and infratentorial ETMR include:

Share article

Article Information

rID: 38525
Section: Pathology
Tag: cases
Synonyms or Alternate Spellings:
  • Ependymoblastoma
  • Embryonal tumour with abundant neuropil and true rosettes (ETANTR)
  • ETANTR
  • Embryonal tumour with abundant neuropil and true rosettes
  • Embryonal tumors with multilayered rosettes
  • ETMR

Support Radiopaedia and see fewer ads

Cases and Figures

  • Drag
    Case 1
    Drag here to reorder.
  • Drag
    Case 2
    Drag here to reorder.
  • Drag
    Case 3
    Drag here to reorder.
  • Drag
    Case 4
    Drag here to reorder.
  • Updating… Please wait.
    Loadinganimation

    Alert accept

    Error Unable to process the form. Check for errors and try again.

    Alert accept Thank you for updating your details.